🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Argenica Therapeutics Limited (ASX:AGN)
Australia flag Australia · Delayed Price · Currency is AUD
0.0700
-0.0300 (-30.00%)
Nov 20, 2026, 2:05 PM AEDT

Argenica Therapeutics Revenue

In the fiscal year ending June 30, 2026, Argenica Therapeutics had annual revenue of 5.48M AUD with 70.66% growth. Argenica Therapeutics had revenue of 4.86M in the half year ending June 30, 2026, with 1,878.64% growth. That makes Argenica Therapeutics the 40,943rd largest company in the world by revenue and 795th in Australia.

Revenue
5.48M
Revenue Growth
+70.66%
P/S Ratio
1.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
8.99M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jun 30, 20265.48M2.27M70.66%
Jun 30, 20253.21M615.81K23.70%
Jun 30, 20242.60M848.04K48.46%
Jun 30, 20231.75M1.49M575.38%
Jun 30, 2022259.10K-36.98K-12.49%
Jun 30, 2021 Pro Pro Pro
Jun 30, 2020 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.